BioSpace News Archive

RootPath, a preclinical-stage biotechnology company aiming to enable personalized, highly-potent T cell therapy powered by its proprietary Synthetic Immunology Platform™, announced a $11 million Series A funding round.

Transgene and NEC Corporation announced that the first patients have been enrolled in the first-in-human trials evaluating TG4050, a therapeutic vaccine based on the myvac™ technology and powered by NEC’s cutting-edge AI capabilities.

InxMed Co., Ltd. announced that the company has entered into a clinical collaboration with a subsidiary of Merck & Co, Inc. Kenilworth, NJ U.S.A., known as MSD outside the United States and Canada, to evaluate IN10018, an investigational proprietary focal adhesion kinase inhibitor in combination with pembrolizumab, MSD’s anti-PD-1 therapy, in patients with pancreatic cancer.

From machines that develop human skills, to intelligent factory automation, personal health devices and social solutions, OMRON shows CES attendees how it is building a better tomorrow [06-January-2020] HOFFMAN ESTATES, Ill. , Jan. 6, 2020 /PRNewswire/ -- Global technology leader OMRON Corporation is showcasing the largest range of its technology at the 2020 Cons

VAXXITEK® HVT+IBD+ND protects against three diseases

Research on Burnout at Osteopathic Medical Schools Also Finds 17% Report High Levels of Depersonalization [06-January-2020] CHICAGO , Jan. 6, 2020 /PRNewswire/ -- Despite the prestige of becoming a physician, 80 percent of medical students report a low sense of personal achievement, according to a new study in The Journal of the American Osteopathic Association .

These inflatable cuffs are designed to be strapped on the upper arm or thigh to practice BFR training as a way to help build muscle and strength.

This transition is difficult for most organizations and includes numerous barriers to success.

Private equity firm Evolution Capital Partners LLC announced its latest growth investment, Empire Dental Arts.

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced that Mark C. Capone, president and CEO, is scheduled to present at the J.P. Morgan 2020 Healthcare Conference at 3:00 p.m. PST on January 13, 2020 in San Francisco..